Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis.


Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 09 04 2018
revised: 31 08 2018
accepted: 31 08 2018
pubmed: 14 11 2018
medline: 30 1 2020
entrez: 14 11 2018
Statut: ppublish

Résumé

Sequencing studies have pointed to the involvement in schizophrenia of rare coding variants in neuronally expressed genes, including activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-D-aspartate receptor (NMDAR) complexes; however, larger samples are required to reveal novel genes and specific biological mechanisms. We sequenced 187 genes, selected for prior evidence of association with schizophrenia, in a new dataset of 5207 cases and 4991 controls. Included among these genes were members of ARC and NMDAR postsynaptic protein complexes, as well as voltage-gated sodium and calcium channels. We performed a rare variant meta-analysis with published sequencing data for a total of 11,319 cases, 15,854 controls, and 1136 trios. While no individual gene was significantly associated with schizophrenia after genome-wide correction for multiple testing, we strengthen the evidence that rare exonic variants in the ARC (p = 4.0 × 10 In one of the largest sequencing studies of schizophrenia to date, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis and confirm the involvement of ARC and NMDAR postsynaptic complexes.

Sections du résumé

BACKGROUND
Sequencing studies have pointed to the involvement in schizophrenia of rare coding variants in neuronally expressed genes, including activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-D-aspartate receptor (NMDAR) complexes; however, larger samples are required to reveal novel genes and specific biological mechanisms.
METHODS
We sequenced 187 genes, selected for prior evidence of association with schizophrenia, in a new dataset of 5207 cases and 4991 controls. Included among these genes were members of ARC and NMDAR postsynaptic protein complexes, as well as voltage-gated sodium and calcium channels. We performed a rare variant meta-analysis with published sequencing data for a total of 11,319 cases, 15,854 controls, and 1136 trios.
RESULTS
While no individual gene was significantly associated with schizophrenia after genome-wide correction for multiple testing, we strengthen the evidence that rare exonic variants in the ARC (p = 4.0 × 10
CONCLUSIONS
In one of the largest sequencing studies of schizophrenia to date, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis and confirm the involvement of ARC and NMDAR postsynaptic complexes.

Identifiants

pubmed: 30420267
pii: S0006-3223(18)31878-X
doi: 10.1016/j.biopsych.2018.08.022
pmc: PMC6428681
pii:
doi:

Substances chimiques

Cytoskeletal Proteins 0
Nerve Tissue Proteins 0
Receptors, N-Methyl-D-Aspartate 0
Voltage-Gated Sodium Channels 0
activity regulated cytoskeletal-associated protein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

554-562

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH077139
Pays : United States
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N01104X/2
Pays : United Kingdom

Investigateurs

Behrooz Z Alizadeh (BZ)
Therese van Amelsvoort (T)
Agna A Bartels-Velthuis (AA)
Nico J van Beveren (NJ)
Richard Bruggeman (R)
Wiepke Cahn (W)
Lieuwe de Haan (L)
Philippe Delespaul (P)
Carin J Meijer (CJ)
Inez Myin-Germeys (I)
Rene S Kahn (RS)
Frederike Schirmbeck (F)
Claudia J P Simons (CJP)
Neeltje E van Haren (NE)
Jim van Os (J)
Ruud van Winkel (R)
Jurjen J Luykx (JJ)

Informations de copyright

Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

Nat Genet. 2014 Sep;46(9):944-50
pubmed: 25086666
Neuropharmacology. 2018 Apr;132:43-57
pubmed: 28927993
Behav Genet. 2018 May;48(3):198-208
pubmed: 29564678
Eur J Hum Genet. 2016 Jun;24(6):944-8
pubmed: 26508570
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Neuron. 2014 May 21;82(4):773-80
pubmed: 24853937
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Nat Genet. 2012 May 29;44(6):623-30
pubmed: 22641211
Cell. 2013 Aug 1;154(3):518-29
pubmed: 23911319
Nat Neurosci. 2016 Nov;19(11):1433-1441
pubmed: 27694994
Br J Psychiatry. 2014 Feb;204(2):108-14
pubmed: 24311552
Nat Genet. 2017 Aug;49(8):1251-1254
pubmed: 28628109
PLoS One. 2014 Nov 24;9(11):e112745
pubmed: 25420024
Sci Rep. 2015 Dec 15;5:18209
pubmed: 26666178
Int J Methods Psychiatr Res. 2012 Sep;21(3):205-21
pubmed: 22419500
Mol Psychiatry. 2014 Jun;19(6):652-8
pubmed: 24776741
Transl Psychiatry. 2015 Jul 21;5:e607
pubmed: 26196440
Nat Genet. 2017 Aug;49(8):1167-1173
pubmed: 28650482
Nat Genet. 2017 Jan;49(1):27-35
pubmed: 27869829
Nat Genet. 2017 Apr;49(4):504-510
pubmed: 28191890
Int J Epidemiol. 2007 Jun;36(3):532-9
pubmed: 17255345
Nat Genet. 2013 Oct;45(10):1150-9
pubmed: 23974872
Nature. 2014 Feb 13;506(7487):179-84
pubmed: 24463507
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Rev Genet. 2012 Jul 10;13(8):537-51
pubmed: 22777127
Neuron. 2015 Jun 3;86(5):1203-14
pubmed: 26050040
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
Nature. 2014 Feb 13;506(7487):185-90
pubmed: 24463508
Nat Genet. 2012 Dec;44(12):1365-9
pubmed: 23042115
Nat Neurosci. 2016 Apr;19(4):571-7
pubmed: 26974950
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Brain. 2012 Sep;135(Pt 9):2585-612
pubmed: 22961543
Mol Psychiatry. 2012 Feb;17(2):142-53
pubmed: 22083728
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Genome Med. 2020 Mar 17;12(1):28
pubmed: 32183904
Nat Genet. 2012 Feb 19;44(3):247-50
pubmed: 22344220
JAMA Psychiatry. 2016 Sep 1;73(9):963-969
pubmed: 27602560
Nat Genet. 2011 Jul 10;43(9):860-3
pubmed: 21743468

Auteurs

Elliott Rees (E)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Noa Carrera (N)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Joanne Morgan (J)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Kirsty Hambridge (K)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Valentina Escott-Price (V)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Andrew J Pocklington (AJ)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Alexander L Richards (AL)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Antonio F Pardiñas (AF)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Colm McDonald (C)

Centre for Neuroimaging and Cognitive Genomics, National University of Ireland Galway, Galway, Ireland.

Gary Donohoe (G)

Centre for Neuroimaging and Cognitive Genomics, National University of Ireland Galway, Galway, Ireland.

Derek W Morris (DW)

Centre for Neuroimaging and Cognitive Genomics, National University of Ireland Galway, Galway, Ireland.

Elaine Kenny (E)

Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.

Eric Kelleher (E)

Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.

Michael Gill (M)

Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.

Aiden Corvin (A)

Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.

George Kirov (G)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

James T R Walters (JTR)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Peter Holmans (P)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Michael J Owen (MJ)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom. Electronic address: owenmj@cardiff.ac.uk.

Michael C O'Donovan (MC)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom. Electronic address: odonovanmc@cardiff.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH